Paracetamol-related hypersensitivity syndrome.

Reference 1 Acetaminophen Risk of drug-induced hypersensitivity syndrome WHO Pharmaceuticals Newsletter: No. 2, 2023. The Japanese Ministry of Health, Labour and Welfare (MHLW) and Pharmaceuticals and Medical Devices Agency (PMDA) have announced that product information for paracetamol (acetaminophen) products should be updated to include the risk of drug-induced hypersensitivity syndrome, according to a report in the I WHO Pharmaceuticals Newsletter i . The MHLW and PMDA assessed 45 cases of drug-induced hypersensitivity syndrome involving paracetamol reported in Japan, and considered that a causal relationship was possible in six cases. [Extracted from the article]